| Literature DB >> 35756195 |
Farhat Gul1, Ilham Khan1, Javed Iqbal2, Banzeer Ahsan Abbasi2, Amir Shahbaz1, Raffaele Capasso3, Itzel Amaro-Estrada4, Yousef A Bin Jardan5, Raquel Cossio-Bayugar4, Tariq Mahmood1,6.
Abstract
Phytochemicals are directly involved in therapeutic treatment or precursors to synthesize useful drugs. The current study was aimed to evaluate the phytocompounds and their biopotentials using methanolic and n-hexane extracts of various parts of Oxalis pes-caprae. For the phytochemical analysis, standard procedures were used, whereas Aluminum Chloride reagent and Follin-ciocalteau reagent methods were used to determine total flavonoid and phenolic contents. Radical scavenging DPPH, phosphomolybdenum reduction, and reducing power assays were used to assess antioxidative potentials. Antibacterial potential was determined by applying disc diffusion method while cytotoxicity was determined employing brine shrimp assay. FT-IR (Fourier-transform infrared) analysis was utilized to gather spectral information, while molecular docking tools were employed to look at how O. pes-caprae plant-based ligands interact with the target protein COVID-19 3CLPro (PDB:6LU7). Phenols, flavonoids, alkaloids and saponins were tested positive in preliminary phytochemical studies. TPC and TFC in different extracts ranging from (38.55 ± 1.72) to (65.68 ± 0.88) mg/g GAE/g and (24.75 ± 1.80) to (14.83 ± 0.92) mg/g QUE/g were used respectively. IC50 value (24.75 ± 0.76 g/mL) by OXFH, total antioxidant capacity (55.89 ± 1.75) mg/g by OXLM, reducing potential (34.98 ± 1.089) mg/g by OXSM, maximum zone of inhibition against B. subtilis (24 ± 0.65 mm) by OXLM and maximum cytotoxicity 96% with LD50 19.66 (μg/mL) by OXSM were the best calculated values among all extracts. Using molecular docking, it was found that Caeruleanone A, 2',4'-Dihydroxy-2″-(1-hydroxy-1-methylethyl) dihydrofuro [2,3-h] flavanone and Vadimezan demonstrated best affinity with the investigated SARS CoV-2 Mpro protein. This work provide justification about this plant as a source of effective phytochemicals and their potential against microbes could lead to development of biosafe drugs for the welfare of human being. In future, different in vitro and in vivo biological studies can be performed to further investigate its biomedical potentials.Entities:
Keywords: Antibacterial; Antioxidant; Cytotoxicity; FTIR; Molecular docking; Oxalis pes-caprae; Phytocompounds; SARS CoV-2 Mpro
Year: 2022 PMID: 35756195 PMCID: PMC9212855 DOI: 10.1016/j.jksus.2022.102136
Source DB: PubMed Journal: J King Saud Univ Sci ISSN: 1018-3647
List of Chemical compounds (Ligands) applied in current study.
| S. No. | Chemical Compound | Formula | Compound CID | Reference | |
|---|---|---|---|---|---|
| 01 | Caeruleanone A | C28H30O7 | 478.5 g/mol | 102231361 | |
| 02 | Loliolide | C11H16O3 | 196.24 g/mol | 100332 | – |
| 03 | Imperatorin | C16H14O4 | 270.28 g/mol | 10212 | |
| 04 | Pterostilbene | C16H16O3 | 256.30 g/mol | 5281727 | – |
| 05 | Butylparaben | C11H14O3 | 194.23 g/mol | 7184 | – |
| 06 | Calycosin | C16H12O5 | 284.26 g/mol | 5280448 | – |
| 07 | Pelubiprofen | C16H18O3 | 258.31 g/mol | 5282203 | – |
| 08 | p-coumaric acid | C9H8O3 | 164.16 g/mol | 637542 | – |
| 09 | 3-Phenylpropionic acid | C9H10O2 | 150.17 g/mol | 107 | – |
| 10 | C9H8O3 | 164.16 g/mol | 1549106 | – | |
| 11 | Cinnamic acid | C9H8O2 | 148.16 g/mol | 444539 | – |
| 12 | 3-methoxyphenol | C7H8O2 | 124.14 g/mol | 9007 | – |
| 13 | 2- methoxyphenol | C9H13NO2 | 167.2 g/mol | 1669 | – |
| 14 | 4-hydroxybenzoic acid | C7H6O3 | 138.12 g/mol | 135 | – |
| 15 | 2,6-Ditert-butyl-4-(1-hydroxyethyl) phenol | C16H26O2 | 250.38 g/mol | 12576677 | – |
| 16 | 3-(1-hydroxyethyl) phenol | C8H10O2 | 138.16 g/mol | 13542886 | – |
| 17 | Tangeretin | C20H20O7 | 372.4 g/mol | 68077 | – |
| 18 | Nobiletin | C21H22O8 | 402.4 g/mol | 72344 | – |
| 19 | Demethylnobiletin | C20H20O8 | 388.4 g/mol | 358832 | – |
| 20 | Vadimezan | C17H14O4 | 282.29 | 123964 | |
| 21 | Zapotin | C19H18O6 | 342.3 | 629965 | – |
| 22 | 2′,4′-Dihydroxy-2″-(1-hydroxy-1-methylethyl) dihydrofuro [2,3-h] flavanone | C20H20O6 | 356.4 | 10291777 | – |
| 23 | 2′-Hydroxy-3,4,4′,6′-tetramethoxychalcone | C19H20O6 | 344.4 | 5373259 | – |
| 24 | Matairesinol | C20H22O6 | 358.4 | 119,205 | – |
Fig. 1Three-dimensional structure of 6LU7 main protease (Mpro): [PDB accession ID: 002214U].
Total flavonoid and phenolic contents.
| Plant extracts | Total flavonoid contents (quercetin mg/g) | Total phenolic contents (gallic acid mg/g) |
|---|---|---|
| 24.75 ± 1.80 | 65.68 ± 0.88 | |
| 22.93 ± 1.82 | 38.55 ± 1.72 | |
| 16.98 ± 1.31 | 53.94 ± 1.48 | |
| 14.83 ± 0.92 | 41.01 ± 1.19 | |
| 23.35 ± 1.35 | 57.04 ± 1.48 | |
| 18.95 ± 0.51 | 61.41 ± 1.55 |
Abbreviations: OXFM = O. pes-caprae flower methanol; OXFH = O. pes-caprae flower n-hexane; OXSM = O. pes-caprae stem methanol; OXSH = O. pes-caprae stem n-hexane; OXLM = O. pes-caprae leave methanol; OXLH = O. pes-caprae leave n-hexane.
Brine shrimp cytotoxicity and DPPH scavenging assay.
| Brine shrimp lethality (μg/mL) | DPPH scavenging activity | ||
|---|---|---|---|
| Percentage mortality | LD50 | IC50 (µg/mL) | |
| Plant samples | 250 (μg/mL) | ||
| OXFM | 82.1 ± 2.42 | 26.46 ± 1.64 | 36.36 ± 0.56 |
| OXFH | 61.90 ± 2.76 | 51.06 ± 2.11 | 24.57 ± 0.76 |
| OXSM | 96.66 ± 1.89 | 19.66 ± 1.98 | 57.1 ± 0.65 |
| OXSH | 76.28 ± 1.60 | 48.78 ± 2.06 | 66.8 ± 0.67 |
| OXLM | 53.29 ± 1.73 | 78.56 ± 1.57 | 46.3 ± 0.76 |
| OXLH | 44.31 ± 2.11 | 102.87 ± 1.90 | 56.2 ± 0.87 |
| Ascorbic acid | – | – | 23.74 ± 0.01 |
Abbreviations: OXFM = O. pes-caprae flower methanol; OXFH = O. pes-caprae flower n-hexane; OXSM = O. pes-caprae stem methanol; OXSH = O. pes-caprae stem n-hexane; OXLM = O. pes-caprae leave methanol; OXLH = O. pes-caprae leave n-hexane.
Fig. 2(A) Total antioxidant capacity (B) total reducing power and (C) antibacterial potential exhibited by different extracts of O. pes-caprae. Through triplicate analysis (means ± SD) were obtained. Abbreviations: OXFM = O. pes-caprae flower methanol; OXFH = O. pes-caprae flower n-hexane; OXSM = O. pes-caprae stem methanol; OXSH = O. pes-caprae stem n-hexane; OXLM = O. pes-caprae leave methanol; OXLH = O. pes-caprae leave n-hexane; OTC = Oxytetracycline.
Fig. 3(A; B) FTIR analysis displays the functional groups and frequency range of inorganic and organic compounds in O. pes-caprae flower.
Fig. 4(A; B) FTIR analysis displays the functional groups and frequency range of inorganic and organic compounds in O. pes-caprae stem.
Two-dimensional structures and the binding strength of investigated ligands with the SARS CoV-2 protein.
| S. No. | Chemical Compound | Chemical structure | Binding affinity (kcal/mol) |
|---|---|---|---|
| 01 | Caeruleanone A | −11.1 | |
| 02 | 2′,4′-Dihydroxy-2″-(1-hydroxy-1-methylethyl) dihydrofuro [2,3-h] flavanone | −10.5 | |
| 03 | Matairesinol | −10.3 | |
| 04 | Vadimezan | −9.6 | |
| 05 | Tangeretin | −9.3 | |
| 06 | Imperatorin | −9.2 | |
| 07 | Nobiletin | −9.2 | |
| 08 | Demethylnobiletin | −9.2 | |
| 09 | 2,6-Ditert-butyl-4-(1-hydroxyethyl) phenol | −9.1 | |
| 10 | Zapotin | −9.0 | |
| 11 | Calycosin | −8.7 | |
| 12 | 2′-Hydroxy-3,4,4′,6′-tetramethoxychalcone | −8.6 | |
| 13 | Pelubiprofen | −8.5 | |
| 14 | Pterostilbene | −7.7 | |
| 15 | Loliolide | −7.2 | |
| 16 | p-coumaric acid | −6.7 | |
| 17 | 3-Phenylpropionic acid | −6.6 | |
| 18 | 2- methoxyphenol | −6.5 | |
| 19 | Butylparaben | −6.5 | |
| 20 | −6.5 | ||
| 21 | Cinnamic acid | −6.1 | |
| 22 | 4-hydroxybenzoic acid | −6.1 | |
| 23 | 3-(1-hydroxyethyl) phenol | −5.7 | |
| 24 | 3-methoxyphenol | −5.0 |
Interactions plots and interacting residues of fourteen potential hits with the SARS CoV-2 Mpro proteins are summarized with the number of hydrophobic interactions and the number of hydrogen bonds (where red spikes represent hydrophobic residues, green-colored residues represent hydrogen bonds).
| S. No. | Chemical | Functional Residues Involved in Hydrophobic Interactions | Total Hydrogen Bonds with Distance | Interaction plots | Binding affinity (kcal/mol) |
|---|---|---|---|---|---|
| 01 | Caeruleanone A | Thr111(A) | (1) | −11.1 | |
| Asn151(A) | Gln107(A) | ||||
| Phe294(A) | NE2-O3 = 2.89 Å | ||||
| Phe8(A) | |||||
| Asp153(A) | |||||
| Ile152(A) | |||||
| Arg105(A) | |||||
| Ile106(A) | |||||
| Gln107(A) | |||||
| 02 | 2′,4′-Dihydroxy-2″-(1-hydroxy-1-methylethyl) dihydrofuro [2,3-h] flavanone | Ile152(A) | (4) Ser158(A) | −10.5 | |
| Asn151(A) | OG-O5 = 3.24 Å | ||||
| Gln110(A) | Asp153(A) | ||||
| Phe294(A) | OD2-O5 = 3.07 Å | ||||
| Val104(A) | Thr111(A) | ||||
| OG1-O3 = 3.24 Å | |||||
| N-O3 = 3.20 Å | |||||
| 03 | Matairesinol | Gln110(A) | (1) | −10.3 | |
| Ile106(A) | Thr111(A) | ||||
| Asn151(A) | OG1-O2 = 3.17 Å | ||||
| Val104(A) | |||||
| Asp153(A) | |||||
| Phe294(A) | |||||
| Ile152(A) | |||||
| 04 | Vadimezan | Gln110(A) | (3) | −9.6 | |
| Thr292(A) | Thr111(A) | ||||
| Phe294(A) | O-O3 = 3.14 Å | ||||
| Asn151(A) | N-O3 = 2.93 Å | ||||
| Ile106(A) | OG1-O3 = 2.83 Å | ||||
| 05 | Tangeretin | Phe294(A) | NO hydrogen bonding | −9.3 | |
| Asn151(A) | |||||
| Arg105(A) | |||||
| Val104(A) | |||||
| Ile106(A) | |||||
| Thr111(A) | |||||
| Gln110(A) | |||||
| 06 | Imperatorin | Gln110(A) | (2) | −9.2 | |
| Gln107(A) | Thr111(A) | ||||
| Ile106(A) | OG1-O4 = 2.75 Å | ||||
| Asn151(A) | N-O4 = 3.08 Å | ||||
| Phe294(A) | |||||
| Thr292(A) | |||||
| 07 | Nobiletin | Thr111(A) | NO hydrogen bonding | −9.2 | |
| Asn151(A) | |||||
| Phe294(A) | |||||
| Gln110(A) | |||||
| Ile106(A) | |||||
| Arg105(A) | |||||
| Val104(A) | |||||
| 08 | Demethylnobiletin | Phe294(A) | (1) | −9.2 | |
| Asn151(A) | Thr111(A) | ||||
| Ile106(A) | O-O5 = 3.19 Å | ||||
| Gln110(A) | |||||
| Arg105(A) | |||||
| Val104(A) | |||||
| 09 | 2,6-Ditert-butyl-4-(1-hydroxyethyl) phenol | Asp295(A) | (3) | −9.1 | |
| Phe294(A) | Thr111(A) | ||||
| Asn151(A) | OG1-O2 = 3.18 Å | ||||
| Ile106(A) | N-O2 = 3.07 Å | ||||
| Gln110(A) | |||||
| NE2-O2 = 3.09 Å | |||||
| 10 | Zapotin | Gln107(A) | (1) | −9.0 | |
| Arg105(A) | Gln110(A) | ||||
| Ile106(A) | NE2-O6 = 2.96 Å | ||||
| Val104(A) | |||||
| Asn151(A) | |||||
| Asp153(A) | |||||
| Phe294(A) | |||||
| 11 | Calycosin | Val104(A) | (3) | −8.7 | |
| Ile106(A) | Asp295(A) | ||||
| Phe294(A) | OD1-O5 = 3.12 Å | ||||
| Asn151(A) | Thr292(A) | ||||
| Ser158(A) | OG1-O5 = 3.30 Å | ||||
| Gln110(A) | Thr111(A) | ||||
| OG1-O5 = 2.72 Å | |||||
| 12 | 2′-Hydroxy-3,4,4′,6′-tetramethoxychalcone | Ile106(A) | (2) | −8.6 | |
| Arg105(A) | Thr111(A) | ||||
| Val104(A) | O-O4 = 3.11 Å | ||||
| Asn151(A) | Gln110(A) | ||||
| Phe294(A) | NE2-O4 = 3.08 Å | ||||
| 13 | Pelubiprofen | Gln110(A) | (2) | −8.5 | |
| Ile106(A) | Thr111(A) | ||||
| Val104(A) | OG1-O2 = 2.90 Å | ||||
| Asn151(A) | N-O3 = 3.19 Å | ||||
| Phe294(A) | (2) | ||||
| 14 | Pterostilbene | Gln110(A) | (2) | −7.7 | |
| Arg105(A) | Asp295(A) | ||||
| Ile106(A) | OD1-O3 = 3.15 Å | ||||
| Val104(A) | Thr111(A) | ||||
| Asn151(A) | OG1-O3 = 2.92 Å | ||||
| Phe294(A) | |||||